Tumor stimulator cell modification by infection with Newcastle Disease Virus: Analysis of effects and mechanism in MLTC-CML cultures

International Journal of Oncology

Volumn 14, Issue 2, 1999, Pages 205-215

  Schirrmacher, Volker ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Cell mediated lympholysis; Cytotoxic T lymphocyte; Interferon; Newcastle disease virus

Indexed keywords

VIRUS ANTIGEN;

ANIMAL; ARTICLE; CARCINOMA; CELL CULTURE; COCULTURE; COLON TUMOR; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; HUMAN; IMMUNOLOGY; MELANOMA; MOUSE; NEWCASTLE DISEASE PARAMYXOVIRUS; PATHOLOGY; VIROLOGY;

ANIMALS; ANTIGENS, VIRAL; CARCINOMA; CELLS, CULTURED; COCULTURE TECHNIQUES; COLONIC NEOPLASMS; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; MELANOMA; MICE; NEWCASTLE DISEASE VIRUS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0033074375     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.14.2.205     Document Type: Article

References (13)

1. Asada T: Treatment of human cancer with mumps virus. Cancer 34: 1907-1928, 1974.
2. Sinkovics J and Horvath J: New developments in the virus therapy of cancer: a historical review. Intervirology 36: 193-214, 1993.
3. Svet-Moldavsky GJ: Tumor-induced skin heterogenization. II. Virus causing the phenomenon. J Natl Cancer Inst 45: 475-484, 1970.
4. Kenney S and Pagano JS: Viruses as oncolytic agents: a new age of Therapeutic' viruses? J Natl Cancer Inst 86: 1185-1186, 1994.
5. Cassel WA and Garret RE: Newcastle Disease Virus as an antineoplastic agent. Cancer 7: 863-868, 1965.
6. Ito Y, Nagai Y and Maeno K: Interferon induction in mice spleen cells and mouse fibroblasts (L cells) stimulated by various strains of Newcastle Disease Virus. J Gen Virol 62: 349-352, 1982.
7. Lorence RM, Rood PA and Kelly KW: Newcastle Disease Virus as an antineoplastic agent: induction of tumor necrosis factor-α and augmentation of ist cytotoxicity. J Natl Cancer Inst 80: 1305-1312, 1988.
8. Reichard KW, Lorence RW, Cascino CJ, Peeples ME, Walter RJ, Fernando MB, Reyes HM and Greager JA: Newcastle Disease Virus selectively kills human cancer cells. J Surg Res 52: 448-453, 1991.
9. Zorn U, Dallmann I, Grosse J, Kirchner H, Poliwoda H and Atzpodien J: Induction of cytokines and cytotoxicity against tumor cells by Newcastle Disease Virus. Cancer Biother 9: 225-234, 1994.
10. Chambers P, Millar NS, Binningham RW and Emmerson PT: Molecular cloning of complementary DNA to Newcastle Disease Virus, and nucleotide sequence analysis of the junction between the genes encoding the hemagglutinin-neuraminidase and the large protein. J Gen Virol 67: 475-486, 1986.
11. Cassel WA, Murray DR and Phillips HS: A phase 2 study on the postsurgical management of stage 2 malignant melanoma with a Newcastle Disease Virus oncolysate. Cancer 52: 856-860, 1983.
12. Cassel WA and Murray DR: A ten-year follow-up stage II malignant melanoma patients treated postsurgically with Newcastle Disease Virus oncolysate. Med Oncol Tumor Pharmacother 9: 169-171, 1992.
13. Kobayashi H: Viral xenogenization of intact tumor cells. Adv Cancer Res 30: 279-299, 1979.